Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Green and Sustainable Chemistry Conference

Posted on April 15th, 2016 by



It felt like an impromptu 25th birthday party for green chemistry. What a feast of speakers there were at the Green and Sustainable Chemistry conference in Berlin last week! Continue reading “Green and Sustainable Chemistry Conference” »

Trail-blazing innovation – Seeking the new blockbuster

Posted on April 11th, 2016 by

Pharma R&D

blockbuster drugs

The Holy Grail of the 21st century, at least for pharmaceutical companies, is the one blockbuster drug that will reap rewards of $1Billion+ in peak sales. Continue reading “Trail-blazing innovation – Seeking the new blockbuster” »

Biosimilars and Pharmacovigilance: 5 Key Challenges

Posted on April 7th, 2016 by


DNA Magnification

The first biosimilar (Zarxio [filgrastim-sndz]) was approved in the US in March 2015, launching what some refer to as a “milestone in the maturity of medical biotechnology.”1 Continue reading “Biosimilars and Pharmacovigilance: 5 Key Challenges” »

A new relationship with Information

Posted on April 5th, 2016 by



Today, new drugs emerge from a diverse landscape of players that includes Pharmaceutical and Biotech companies, as well as Academia – a veritable ecosystem of innovation. The role of Academia in this ecosystem is unique. Continue reading “A new relationship with Information” »

Getting the message across

Posted on April 1st, 2016 by



If you ever get out of the laboratory or office onto the street, look around and you can be certain that most people you see will not be concentrating on where they are walking (or, here in the Netherlands, where they are cycling) Continue reading “Getting the message across” »

Computers + Chemistry: Some Thoughts from ACS San Diego

Posted on March 31st, 2016 by



I’ve just returned home from the 251st American Chemical Society (ACS) Meeting and Exposition in San Diego. While recovering from my jet lag, Continue reading “Computers + Chemistry: Some Thoughts from ACS San Diego” »

  1. 1
  2. 36
  3. 37
  4. 38
  5. 39
  6. 40
  7. 47

About this Blog


The Elsevier Pharma R&D blog provides insight and opinion on topics related to pharmaceutical research and development, namely: big data, target identification, new drug discovery, drug safety monitoring, risk mitigation and regulatory compliance. We serve the community of chemists, scientists, drug safety specialists, educators and students interested in pharmaceutical R&D.

Editor’s note: The views and opinions expressed are those of the author and do not necessarily reflect the views of Elsevier,  its affiliates and sponsors or its parent company, Reed Elsevier.